• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Retinoid X receptor gamma signaling accelerates CNS remyelination.视黄酸 X 受体 γ 信号通路加速中枢神经系统髓鞘再生。
Nat Neurosci. 2011 Jan;14(1):45-53. doi: 10.1038/nn.2702. Epub 2010 Dec 5.
2
Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.成年少突胶质前体细胞中结节性硬化复合物1的缺失可增强轴突再髓鞘化,并在局灶性脱髓鞘后增加髓鞘厚度。
J Neurosci. 2017 Aug 2;37(31):7534-7546. doi: 10.1523/JNEUROSCI.3454-16.2017. Epub 2017 Jul 10.
3
Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination.核受体PPARγ以GPNMB为靶点,促进少突胶质细胞发育和髓鞘再生。
Brain. 2025 May 13;148(5):1801-1816. doi: 10.1093/brain/awae378.
4
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.基于药物的内源性干细胞调节促进体内功能性髓鞘再生。
Nature. 2015 Jun 11;522(7555):216-20. doi: 10.1038/nature14335. Epub 2015 Apr 20.
5
The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.少突胶质细胞和少突胶质前体细胞在中枢神经系统髓鞘再生中的作用。
Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15.
6
Effects of electroacupuncture and the retinoid X receptor (RXR) signalling pathway on oligodendrocyte differentiation in the demyelinated spinal cord of rats.电针及视黄酸X受体(RXR)信号通路对大鼠脱髓鞘脊髓少突胶质细胞分化的影响。
Acupunct Med. 2017 Apr;35(2):122-132. doi: 10.1136/acupmed-2016-011134. Epub 2016 Oct 24.
7
Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.在没有星形胶质细胞的情况下,内源性Nkx2.2+/Olig2+少突胶质前体细胞无法使成年大鼠脱髓鞘的脊髓重新髓鞘化。
Exp Neurol. 2005 Mar;192(1):11-24. doi: 10.1016/j.expneurol.2004.05.038.
8
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.纤维连接蛋白在多发性硬化病变中的聚集会损害髓鞘的修复。
Brain. 2013 Jan;136(Pt 1):116-31. doi: 10.1093/brain/aws313.
9
The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.从成年大鼠中枢神经系统分离出的表达髓鞘少突胶质细胞糖蛋白(MOG)的少突胶质前体细胞的髓鞘再生潜力及体外分化
Eur J Neurosci. 2004 Sep;20(6):1445-60. doi: 10.1111/j.1460-9568.2004.03606.x.
10
The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.在实验性自身免疫性脑脊髓炎(MOG-EAE)和多发性硬化症(MS)中,表达NG2的少突胶质细胞前体细胞对脱髓鞘的反应。
J Neurocytol. 2002 Jul-Aug;31(6-7):523-36. doi: 10.1023/a:1025747832215.

引用本文的文献

1
RXRG as a Novel Biomarker and its Correlation With Immune Infiltration in Thyroid Carcinoma.视黄酸受体γ(RXRG)作为一种新型生物标志物及其与甲状腺癌免疫浸润的相关性。
In Vivo. 2025 Jul-Aug;39(4):2013-2034. doi: 10.21873/invivo.13998.
2
Role of Nuclear Receptors on the Progression of Multiple Sclerosis: A Review.核受体在多发性硬化症进展中的作用:综述
Cell Mol Neurobiol. 2025 Jun 17;45(1):58. doi: 10.1007/s10571-025-01563-z.
3
Oligodendroglia in Ageing and Age-Dependent Neurodegenerative Diseases.衰老及年龄相关性神经退行性疾病中的少突胶质细胞
Adv Neurobiol. 2025;43:363-405. doi: 10.1007/978-3-031-87919-7_13.
4
A Computational Approach to Identify Novel Protein Targets Uncovers New Potential Mechanisms of Action of Mirtazapine S(+) and R(-) Enantiomers in Rett Syndrome.一种识别新型蛋白质靶点的计算方法揭示了米氮平S(+)和R(-)对映体在雷特综合征中的新潜在作用机制。
J Neurochem. 2025 May;169(5):e70093. doi: 10.1111/jnc.70093.
5
The potential of repurposing clemastine to promote remyelination.重新利用氯马斯汀促进髓鞘再生的潜力。
Front Cell Neurosci. 2025 May 7;19:1582902. doi: 10.3389/fncel.2025.1582902. eCollection 2025.
6
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.RXRγ的相分离驱动肿瘤化疗耐药,并代表小细胞肺癌的一个治疗靶点。
Proc Natl Acad Sci U S A. 2025 May 27;122(21):e2421199122. doi: 10.1073/pnas.2421199122. Epub 2025 May 20.
7
MRI signatures of cortical microstructure in human development align with oligodendrocyte cell-type expression.人类发育过程中皮质微结构的磁共振成像特征与少突胶质细胞类型表达一致。
Nat Commun. 2025 Apr 7;16(1):3317. doi: 10.1038/s41467-025-58604-w.
8
The crosstalk between CNS resident glial cells and peripheral immune cells is critical for age-dependent demyelination and subsequent remyelination.中枢神经系统常驻神经胶质细胞与外周免疫细胞之间的相互作用对于年龄依赖性脱髓鞘及随后的髓鞘再生至关重要。
Biogerontology. 2025 Mar 14;26(2):74. doi: 10.1007/s10522-025-10213-2.
9
Retinoid X receptor agonist 9CDHRA mitigates retinal ganglion cell apoptosis and neuroinflammation in a mouse model of glaucoma.维甲酸X受体激动剂9CDHRA减轻青光眼小鼠模型中的视网膜神经节细胞凋亡和神经炎症。
FASEB J. 2025 Mar 31;39(6):e70465. doi: 10.1096/fj.202402642R.
10
Intrinsic retinoic acid synthesis is required for oligodendrocyte progenitor expansion during CNS remyelination.在中枢神经系统再髓鞘化过程中,少突胶质细胞祖细胞的扩增需要内源性视黄酸的合成。
Front Cell Neurosci. 2025 Feb 24;19:1550139. doi: 10.3389/fncel.2025.1550139. eCollection 2025.

本文引用的文献

1
Retinoid X receptors: common heterodimerization partners with distinct functions.视黄酸 X 受体:具有不同功能的常见异二聚体伙伴。
Trends Endocrinol Metab. 2010 Nov;21(11):676-83. doi: 10.1016/j.tem.2010.06.009. Epub 2010 Jul 30.
2
Retinoid x receptor gamma control of affective behaviors involves dopaminergic signaling in mice.视黄酸受体γ控制小鼠的情感行为涉及多巴胺能信号。
Neuron. 2010 Jun 24;66(6):908-20. doi: 10.1016/j.neuron.2010.05.004.
3
Chronic expression of PPAR-delta by oligodendrocyte lineage cells in the injured rat spinal cord.少突胶质细胞系细胞中过氧化物酶体增殖物激活受体-δ的慢性表达与大鼠损伤脊髓。
J Comp Neurol. 2010 Mar 15;518(6):785-99. doi: 10.1002/cne.22242.
4
An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation.整合素-接触蛋白复合物通过差异性Fyn磷酸化调节中枢神经系统髓鞘形成。
J Neurosci. 2009 Jul 22;29(29):9174-85. doi: 10.1523/JNEUROSCI.5942-08.2009.
5
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.Wnt信号通路的失调会抑制哺乳动物中枢神经系统中髓鞘的及时形成和再髓鞘化。
Genes Dev. 2009 Jul 1;23(13):1571-85. doi: 10.1101/gad.1806309. Epub 2009 Jun 10.
6
Remyelination capacity of the MS brain decreases with disease chronicity.多发性硬化症患者大脑的再髓鞘化能力会随着疾病慢性化而下降。
Neurology. 2009 Jun 2;72(22):1914-21. doi: 10.1212/WNL.0b013e3181a8260a.
7
Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis.合成维甲酸AM80抑制辅助性T细胞17并改善实验性自身免疫性脑脊髓炎。
Am J Pathol. 2009 Jun;174(6):2234-45. doi: 10.2353/ajpath.2009.081084. Epub 2009 Apr 23.
8
25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR.25-羟基胆固醇通过肝X受体β和孕烷X受体引发少突胶质细胞系凋亡并刺激IIA型分泌型磷脂酶A2。
J Neurochem. 2009 May;109(4):945-58. doi: 10.1111/j.1471-4159.2009.06009.x. Epub 2009 Feb 24.
9
Remyelination in the CNS: from biology to therapy.中枢神经系统中的髓鞘再生:从生物学到治疗
Nat Rev Neurosci. 2008 Nov;9(11):839-55. doi: 10.1038/nrn2480.
10
The RXR agonists PA024 and HX630 have different abilities to activate LXR/RXR and to induce ABCA1 expression in macrophage cell lines.视黄酸X受体(RXR)激动剂PA024和HX630在巨噬细胞系中激活肝X受体(LXR)/视黄酸X受体(RXR)以及诱导ATP结合盒转运体A1(ABCA1)表达的能力不同。
Biochem Pharmacol. 2008 Oct 15;76(8):1006-13. doi: 10.1016/j.bcp.2008.08.005. Epub 2008 Aug 12.

视黄酸 X 受体 γ 信号通路加速中枢神经系统髓鞘再生。

Retinoid X receptor gamma signaling accelerates CNS remyelination.

机构信息

MRC Centre for Stem Cell Biology and Regenerative Medicine and Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.

MRC Centre for Regenerative Medicine and Multiple Sclerosis Society/University of Edinburgh Centre for Translational Research, Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, UK.

出版信息

Nat Neurosci. 2011 Jan;14(1):45-53. doi: 10.1038/nn.2702. Epub 2010 Dec 5.

DOI:10.1038/nn.2702
PMID:21131950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4013508/
Abstract

The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-γ were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-γ in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-γ by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-γ, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.

摘要

中枢神经系统髓鞘再生(再髓鞘化)的分子基础知之甚少。我们生成了一个大鼠中枢神经系统局灶性脱髓鞘后自发再髓鞘化各阶段的综合转录谱,发现编码视黄酸受体 RXR-γ的转录本在再髓鞘化过程中存在差异表达。在经历再髓鞘化的大鼠组织以及活动期和再髓鞘化多发性硬化病变中,寡突胶质细胞谱系的细胞表达 RXR-γ。用 RNA 干扰或 RXR 特异性拮抗剂敲低 RXR-γ,严重抑制了培养中的少突胶质细胞分化。在缺乏 RXR-γ的小鼠中,成年少突胶质前体细胞在脱髓鞘后能有效地重新填充病变,但向成熟少突胶质细胞的分化延迟。在脱髓鞘小脑切片培养物和脱髓鞘后老龄大鼠中给予 RXR 激动剂 9-顺式视黄酸,可导致再髓鞘化轴突增加。我们的结果表明,RXR-γ 是内源性少突胶质前体细胞分化和再髓鞘化的正调节剂,可能是中枢神经系统再生治疗的药理学靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/e3bd8049671c/emss-58230-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/ff34ab63d1cb/emss-58230-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/59165fd6b138/emss-58230-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/b0dfc7fb26a8/emss-58230-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/2722f105983c/emss-58230-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/6db6fcfbf94f/emss-58230-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/e3bd8049671c/emss-58230-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/ff34ab63d1cb/emss-58230-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/59165fd6b138/emss-58230-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/b0dfc7fb26a8/emss-58230-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/2722f105983c/emss-58230-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/6db6fcfbf94f/emss-58230-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/4013508/e3bd8049671c/emss-58230-f0006.jpg